HR
BIO icon

Howe & Rusling’s Bio-Rad Laboratories Class A BIO Stock Holding History

Howe & Rusling’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8
Closed -$5K – 950
2021
Q1 		$5K Hold
8
– – ﹤0.01% 605
2020
Q4 		$5K Sell
8
-2
-20% -$1.14K ﹤0.01% 594
2020
Q3 		$5K Sell
10
-8
-44% -$4.05K ﹤0.01% 533
2020
Q2 		$8K Buy
18
+3
+20% +$1.32K ﹤0.01% 458
2020
Q1 		$5K Hold
15
– – ﹤0.01% 500
2019
Q4 		$6K Hold
15
– – ﹤0.01% 522
2019
Q3 		$5K Hold
15
– – ﹤0.01% 544
2019
Q2 		$5K Sell
15
-2
-12% -$599 ﹤0.01% 524
2019
Q1 		$5K Buy
17
+2
+13% +$540 ﹤0.01% 531
2018
Q4 		$3K Sell
15
-5
-25% -$1.34K ﹤0.01% 600
2018
Q3 		$6K Hold
20
– – ﹤0.01% 577
2018
Q2 		$6K Buy
20
+3
+18% +$828 ﹤0.01% 522
2018
Q1 		$4K Buy
+17
New +$4.33K ﹤0.01% 640
2014
Q2 		– Sell
-304
Closed -$39K – 844
2014
Q1 		$39K Buy
+304
New +$39K 0.01% 361
2013
Q4 		– Sell
-331
Closed -$39K – 812
2013
Q3 		$39K Sell
331
-16
-5% -$1.89K 0.01% 364
2013
Q2 		$39K Buy
+347
New +$40.7K 0.01% 375

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Howe & Rusling's BIO Position: Q2 2021 in Review

Howe & Rusling sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2021, closing a stake of 8 shares — an estimated $5K sold.

Howe & Rusling first reported a position in BIO in Q2 2013 and held it in 16 quarters. The position peaked at $39K in Q1 2014. 509 funds tracked by Wall St. Rank hold BIO as of Q2 2021.

  • Howe & Rusling reported no remaining Bio-Rad Laboratories Class A position as of Q2 2021 after selling out during the quarter.
  • Howe & Rusling sold 8 Bio-Rad Laboratories Class A shares in Q2 2021, an estimated $5K.
  • Howe & Rusling first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 16 quarters.
  • Howe & Rusling's Bio-Rad Laboratories Class A position peaked at $39K in Q1 2014.
  • 509 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2021.

Based on Howe & Rusling's 13F filing for Q2 2021, filed 13 Aug 2021.